Lipid Disorder Treatment Global Market Report 2025

Published Apr 01, 2025

Length 200 Pages

SKU # BRC19896756

Description

Lipid Disorder Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lipid disorder treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for lipid disorder treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lipid disorder treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Type: Atorvastatin; Fluvastatin; Rosuvastatin; Simvastatin; Pravastatin; Other Drugs

2) By Indication: Familial Combined Hyperlipidemia; Familial Defective Apolipoprotein B-100; Familial Dysbetalipoproteinemia; Familial Hypertriglyceridemia; Heterozygous Familial Hypercholesterolemia; Other Indications

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels

Subsegments:

1) By Atorvastatin: Generic Atorvastatin; Brand-Name Atorvastatin ( Lipitor)

2) By Fluvastatin: Generic Fluvastatin; Brand-Name Fluvastatin ( Lescol)

3) By Rosuvastatin: Generic Rosuvastatin; Brand-Name Rosuvastatin ( Crestor)

4) By Simvastatin: Generic Simvastatin; Brand-Name Simvastatin ( Zocor)

5) By Pravastatin: Generic Pravastatin; Brand-Name Pravastatin ( Pravachol)

6) By Other Drugs: Ezetimibe; Pcsk9 Inhibitors ( Alirocumab, Evolocumab); Fibrates ( Gemfibrozil, Fenofibrate); Niacin (Vitamin B3); Omega-3 Fatty Acids ( Icosapent Ethyl)

Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Merck & Co. Inc.; Sanofi S.A.; AstraZeneca Plc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

1. Executive Summary
2. Lipid Disorder Treatment Market Characteristics
3. Lipid Disorder Treatment Market Trends And Strategies
4. Lipid Disorder Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Lipid Disorder Treatment Growth Analysis And Strategic Analysis Framework: 5.1. Global Lipid Disorder Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints); 5.2. Analysis Of End Use Industries; 5.3. Global Lipid Disorder Treatment Market Growth Rate Analysis; 5.4. Global Lipid Disorder Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion); 5.5. Global Lipid Disorder Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion); 5.6. Global Lipid Disorder Treatment Total Addressable Market (TAM)
6. Lipid Disorder Treatment Market Segmentation: 6.1. Global Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Atorvastatin; Fluvastatin; Rosuvastatin; Simvastatin; Pravastatin; Other Drugs; 6.2. Global Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Familial Combined Hyperlipidemia; Familial Defective Apolipoprotein B-100; Familial Dysbetalipoproteinemia; Familial Hypertriglyceridemia; Heterozygous Familial Hypercholesterolemia; Other Indications; 6.3. Global Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels; 6.4. Global Lipid Disorder Treatment Market, Sub-Segmentation Of Atorvastatin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Generic Atorvastatin; Brand-Name Atorvastatin (Lipitor); 6.5. Global Lipid Disorder Treatment Market, Sub-Segmentation Of Fluvastatin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Generic Fluvastatin; Brand-Name Fluvastatin (Lescol); 6.6. Global Lipid Disorder Treatment Market, Sub-Segmentation Of Rosuvastatin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Generic Rosuvastatin; Brand-Name Rosuvastatin (Crestor); 6.7. Global Lipid Disorder Treatment Market, Sub-Segmentation Of Simvastatin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Generic Simvastatin; Brand-Name Simvastatin (Zocor); 6.8. Global Lipid Disorder Treatment Market, Sub-Segmentation Of Pravastatin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Generic Pravastatin; Brand-Name Pravastatin (Pravachol); 6.9. Global Lipid Disorder Treatment Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Ezetimibe; PCSK9 Inhibitors (Alirocumab, Evolocumab); Fibrates (Gemfibrozil, Fenofibrate); Niacin (Vitamin B3); Omega-3 Fatty Acids (Icosapent Ethyl)
7. Lipid Disorder Treatment Market Regional And Country Analysis: 7.1. Global Lipid Disorder Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 7.2. Global Lipid Disorder Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Lipid Disorder Treatment Market: 8.1. Asia-Pacific Lipid Disorder Treatment Market Overview; Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies; 8.2. Asia-Pacific Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.3. Asia-Pacific Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.4. Asia-Pacific Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Lipid Disorder Treatment Market: 9.1. China Lipid Disorder Treatment Market Overview; 9.2. China Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.3. China Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.4. China Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Lipid Disorder Treatment Market: 10.1. India Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.2. India Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.3. India Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Lipid Disorder Treatment Market: 11.1. Japan Lipid Disorder Treatment Market Overview; 11.2. Japan Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.3. Japan Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.4. Japan Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Lipid Disorder Treatment Market: 12.1. Australia Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.2. Australia Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.3. Australia Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Lipid Disorder Treatment Market: 13.1. Indonesia Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.2. Indonesia Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.3. Indonesia Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Lipid Disorder Treatment Market: 14.1. South Korea Lipid Disorder Treatment Market Overview; 14.2. South Korea Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.3. South Korea Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.4. South Korea Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Lipid Disorder Treatment Market: 15.1. Western Europe Lipid Disorder Treatment Market Overview; 15.2. Western Europe Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.3. Western Europe Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.4. Western Europe Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Lipid Disorder Treatment Market: 16.1. UK Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.2. UK Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.3. UK Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Lipid Disorder Treatment Market: 17.1. Germany Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.2. Germany Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.3. Germany Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Lipid Disorder Treatment Market: 18.1. France Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.2. France Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.3. France Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Lipid Disorder Treatment Market: 19.1. Italy Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.2. Italy Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.3. Italy Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Lipid Disorder Treatment Market: 20.1. Spain Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.2. Spain Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.3. Spain Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Lipid Disorder Treatment Market: 21.1. Eastern Europe Lipid Disorder Treatment Market Overview; 21.2. Eastern Europe Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.3. Eastern Europe Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.4. Eastern Europe Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Lipid Disorder Treatment Market: 22.1. Russia Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.2. Russia Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.3. Russia Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Lipid Disorder Treatment Market: 23.1. North America Lipid Disorder Treatment Market Overview; 23.2. North America Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.3. North America Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.4. North America Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Lipid Disorder Treatment Market: 24.1. USA Lipid Disorder Treatment Market Overview; 24.2. USA Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.3. USA Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.4. USA Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Lipid Disorder Treatment Market: 25.1. Canada Lipid Disorder Treatment Market Overview; 25.2. Canada Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.3. Canada Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.4. Canada Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Lipid Disorder Treatment Market: 26.1. South America Lipid Disorder Treatment Market Overview; 26.2. South America Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.3. South America Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.4. South America Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Lipid Disorder Treatment Market: 27.1. Brazil Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.2. Brazil Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.3. Brazil Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Lipid Disorder Treatment Market: 28.1. Middle East Lipid Disorder Treatment Market Overview; 28.2. Middle East Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.3. Middle East Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.4. Middle East Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Lipid Disorder Treatment Market: 29.1. Africa Lipid Disorder Treatment Market Overview; 29.2. Africa Lipid Disorder Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.3. Africa Lipid Disorder Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.4. Africa Lipid Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Lipid Disorder Treatment Market Competitive Landscape And Company Profiles: 30.1. Lipid Disorder Treatment Market Competitive Landscape; 30.2. Lipid Disorder Treatment Market Company Profiles; 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis; 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis; 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis; 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis; 30.2.5. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
31. Lipid Disorder Treatment Market Other Major And Innovative Companies: 31.1. Fresenius SE & Co. KGaA; 31.2. Abbott Laboratories Inc.; 31.3. Novartis AG; 31.4. GlaxoSmithKline Plc; 31.5. Wockhardt Ltd.; 31.6. Eli Lilly and Company; 31.7. Amgen Inc.; 31.8. Boehringer-Ingelheim International GmbH; 31.9. Viatris Inc.; 31.10. Teva Pharmaceutical Industries Ltd.; 31.11. Regeneron Pharmaceuticals Inc.; 31.12. Mylan N.V.; 31.13. Kaneka Corporation; 31.14. Sun Pharmaceutical Industries Ltd.; 31.15. Glenmark Pharmaceuticals Limited
32. Global Lipid Disorder Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Lipid Disorder Treatment Market
34. Recent Developments In The Lipid Disorder Treatment Market
35. Lipid Disorder Treatment Market High Potential Countries, Segments and Strategies: 35.1 Lipid Disorder Treatment Market In 2029 - Countries Offering Most New Opportunities; 35.2 Lipid Disorder Treatment Market In 2029 - Segments Offering Most New Opportunities; 35.3 Lipid Disorder Treatment Market In 2029 - Growth Strategies; 35.3.1 Market Trend Based Strategies; 35.3.2 Competitor Strategies
36. Appendix: 36.1. Abbreviations; 36.2. Currencies; 36.3. Historic And Forecast Inflation Rates; 36.4. Research Inquiries; 36.5. The Business Research Company; 36.6. Copyright And Disclaimer

Pricing

Currency Rates

Single User Email from Publisher $4,490
Site License Fulfilled by Publisher $6,490
Global Site License Email from Publisher $8,490

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now